Logo image of CMRC

COMMERCE.COM INC (CMRC) Stock Fundamental Analysis

USA - NASDAQ:CMRC - US08975P1084 - Common Stock

4.95 USD
+0.1 (+2.06%)
Last: 10/21/2025, 7:52:28 PM
4.98 USD
+0.03 (+0.61%)
After Hours: 10/21/2025, 7:52:28 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CMRC. CMRC was compared to 86 industry peers in the IT Services industry. While CMRC seems to be doing ok healthwise, there are quite some concerns on its profitability. CMRC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CMRC had positive earnings in the past year.
In the past year CMRC had a positive cash flow from operations.
CMRC had negative earnings in each of the past 5 years.
In the past 5 years CMRC reported 4 times negative operating cash flow.
CMRC Yearly Net Income VS EBIT VS OCF VS FCFCMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.99%, CMRC is doing worse than 70.93% of the companies in the same industry.
The Return On Equity of CMRC (-46.74%) is worse than 76.74% of its industry peers.
Industry RankSector Rank
ROA -5.99%
ROE -46.74%
ROIC N/A
ROA(3y)-17.34%
ROA(5y)-15.95%
ROE(3y)-213.47%
ROE(5y)-142.73%
ROIC(3y)N/A
ROIC(5y)N/A
CMRC Yearly ROA, ROE, ROICCMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

Looking at the Gross Margin, with a value of 78.06%, CMRC belongs to the top of the industry, outperforming 96.51% of the companies in the same industry.
CMRC's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CMRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
CMRC Yearly Profit, Operating, Gross MarginsCMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

CMRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CMRC has been increased compared to 1 year ago.
CMRC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CMRC has an improved debt to assets ratio.
CMRC Yearly Shares OutstandingCMRC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CMRC Yearly Total Debt VS Total AssetsCMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

CMRC has an Altman-Z score of -0.62. This is a bad value and indicates that CMRC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CMRC (-0.62) is worse than 82.56% of its industry peers.
CMRC has a debt to FCF ratio of 6.27. This is a slightly negative value and a sign of low solvency as CMRC would need 6.27 years to pay back of all of its debts.
The Debt to FCF ratio of CMRC (6.27) is comparable to the rest of the industry.
A Debt/Equity ratio of 4.06 is on the high side and indicates that CMRC has dependencies on debt financing.
The Debt to Equity ratio of CMRC (4.06) is worse than 86.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF 6.27
Altman-Z -0.62
ROIC/WACCN/A
WACC7.21%
CMRC Yearly LT Debt VS Equity VS FCFCMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CMRC has a Current Ratio of 2.13. This indicates that CMRC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.13, CMRC is in the better half of the industry, outperforming 61.63% of the companies in the same industry.
A Quick Ratio of 2.13 indicates that CMRC has no problem at all paying its short term obligations.
CMRC's Quick ratio of 2.13 is fine compared to the rest of the industry. CMRC outperforms 62.79% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.13
CMRC Yearly Current Assets VS Current LiabilitesCMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.33% over the past year.
CMRC shows a small growth in Revenue. In the last year, the Revenue has grown by 4.05%.
The Revenue has been growing by 24.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)4.05%
Revenue growth 3Y14.83%
Revenue growth 5Y24.32%
Sales Q2Q%3.18%

3.2 Future

The Earnings Per Share is expected to grow by 14.37% on average over the next years. This is quite good.
Based on estimates for the next years, CMRC will show a small growth in Revenue. The Revenue will grow by 4.71% on average per year.
EPS Next Y-23.9%
EPS Next 2Y5.22%
EPS Next 3Y14.37%
EPS Next 5YN/A
Revenue Next Year3.24%
Revenue Next 2Y3.95%
Revenue Next 3Y4.71%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CMRC Yearly Revenue VS EstimatesCMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CMRC Yearly EPS VS EstimatesCMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.68, CMRC is valued on the expensive side.
Based on the Price/Earnings ratio, CMRC is valued a bit cheaper than 72.09% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.77, CMRC is valued a bit cheaper.
CMRC is valuated correctly with a Price/Forward Earnings ratio of 15.97.
Based on the Price/Forward Earnings ratio, CMRC is valued a bit cheaper than 73.26% of the companies in the same industry.
CMRC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.23.
Industry RankSector Rank
PE 17.68
Fwd PE 15.97
CMRC Price Earnings VS Forward Price EarningsCMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CMRC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CMRC is more expensive than 69.77% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CMRC indicates a somewhat cheap valuation: CMRC is cheaper than 74.42% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.91
EV/EBITDA 215.36
CMRC Per share dataCMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as CMRC's earnings are expected to grow with 14.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.22%
EPS Next 3Y14.37%

0

5. Dividend

5.1 Amount

No dividends for CMRC!.
Industry RankSector Rank
Dividend Yield N/A

COMMERCE.COM INC

NASDAQ:CMRC (10/21/2025, 7:52:28 PM)

After market: 4.98 +0.03 (+0.61%)

4.95

+0.1 (+2.06%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners70.06%
Inst Owner ChangeN/A
Ins Owners10.48%
Ins Owner Change7.18%
Market Cap399.66M
Analysts70
Price Target7.48 (51.11%)
Short Float %8.14%
Short Ratio6.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.46%
Min EPS beat(2)15%
Max EPS beat(2)29.93%
EPS beat(4)4
Avg EPS beat(4)68.16%
Min EPS beat(4)15%
Max EPS beat(4)168.48%
EPS beat(8)8
Avg EPS beat(8)76.94%
EPS beat(12)12
Avg EPS beat(12)68.23%
EPS beat(16)14
Avg EPS beat(16)54.08%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.04%
Max Revenue beat(2)-0.64%
Revenue beat(4)0
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-2.04%
Max Revenue beat(4)-0.64%
Revenue beat(8)2
Avg Revenue beat(8)-0.7%
Revenue beat(12)4
Avg Revenue beat(12)-0.63%
Revenue beat(16)8
Avg Revenue beat(16)0.24%
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)-8.62%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.68
Fwd PE 15.97
P/S 1.18
P/FCF 15.91
P/OCF 12.53
P/B 10.31
P/tB N/A
EV/EBITDA 215.36
EPS(TTM)0.28
EY5.66%
EPS(NY)0.31
Fwd EY6.26%
FCF(TTM)0.31
FCFY6.29%
OCF(TTM)0.39
OCFY7.98%
SpS4.18
BVpS0.48
TBVpS-0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.99%
ROE -46.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.06%
FCFM 7.44%
ROA(3y)-17.34%
ROA(5y)-15.95%
ROE(3y)-213.47%
ROE(5y)-142.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score6
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF 6.27
Debt/EBITDA 103.92
Cap/Depr 45.32%
Cap/Sales 2.01%
Interest Coverage N/A
Cash Conversion 2103.63%
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 2.13
Altman-Z -0.62
F-Score6
WACC7.21%
ROIC/WACCN/A
Cap/Depr(3y)35.32%
Cap/Depr(5y)44.65%
Cap/Sales(3y)1.44%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y-23.9%
EPS Next 2Y5.22%
EPS Next 3Y14.37%
EPS Next 5YN/A
Revenue 1Y (TTM)4.05%
Revenue growth 3Y14.83%
Revenue growth 5Y24.32%
Sales Q2Q%3.18%
Revenue Next Year3.24%
Revenue Next 2Y3.95%
Revenue Next 3Y4.71%
Revenue Next 5YN/A
EBIT growth 1Y65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.8%
EBIT Next 3Y46.98%
EBIT Next 5YN/A
FCF growth 1Y139.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y153.52%
OCF growth 3YN/A
OCF growth 5YN/A